The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases

NCT05764343 | Completed DMC

• 1 other identifier: EKGG
• Study Type: interventional
• Target: 397
• Locations: 1 country
• Sites: 1

Brief Summary

Smoking cessation support is provided by smoking cessation outpatient clinics in our country. Smokers with chronic airway diseases can also apply to these services by making an appointment from quit lines. Quit rates of that group patients were found to be similar to the general population. In novel smoking cessation support approaches immediate cessation support is reported to be more effective than routine practice. The sample in these studies consists of individuals who applied for lung health screening programmes. There is no study in the literature examining the effect of this immediate support on patients with chronic airway diseases' quit success. Our aim with this study is to examine impact of immediate cessation support by getting an appointment to the same cessation clinic instantly on our sample's cessation success.

Conditions

Tobacco Cessation; Asthma COPD; Bronchiectasis Adult

Keywords

tobacco cessation; asthma; COPD; bronchiectasis; immediate cessation support

Outcome Measures

Primary Outcomes (1)

• Quit rate of both study arms

  To compare the quit rate at third month of randomization in the both arms: intensive support arm compared to routine support arm. A quitter will be considered who have never smoked since the target quit day.

  At third month of randomization

Secondary Outcomes (1)

• Smoking cessation outpatient clinic application rate of both study arms

  At third month

Study Arms (2)

Routine support/care arm

NO INTERVENTION

As the followed routine implementation, this group will be given a brief smoking cessation intervention and will be recommended to apply to smoking cessation outpatient clinics by getting an appointment from quit services.

Immediate support arm

ACTIVE COMPARATOR

Those randomized to this group will have an immediate appointment at the smoking cessation outpatient clinic in addition to the brief smoking cessation intervention.

Other: Immediate smoking cessation support

Interventions

Immediate smoking cessation support OTHER

Smoker patients with chronic airway diseases (asthma and/or COPD and/or bronchiectasis) will be evaluated for the inclusion criteria. Afterwards they will be randomized as routine support arm (as the current procedure of the care) and immediate support arm (intensive brief cessation advices following by the immediate arrangement of the appointment from the same clinic's smoking cessation service). Both arms will be followed remotely at first week and third months of the randomization regarding their quit status as well as their use of evidence based cessation treatments.

Immediate support arm

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Being age 18 years and over,
• Having diagnoses of asthma and/or COPD and/or bronchiectasis for at least 6 months,
• Applying to the chest diseases outpatient clinics,
• Being an current smoker,
• Those who agree to participate in the study,
• Patients who can be reached by phone calls at 1 week and 3 months after randomization.

You may not qualify if:

• Those with active psychiatric disorders
• Patients with impaired cognitive functions.

Sponsors & Collaborators

• Recep Tayyip Erdogan University Training and Research Hospital: lead
• Turkish Thoracic Society: collaborator

Study Sites (1)

Recep Tayyip Erdoğan University, Training and Research Hospital

Rize, Turkey (Türkiye)

Location

Related Publications (5)

• Jimenez-Ruiz CA, Andreas S, Lewis KE, Tonnesen P, van Schayck CP, Hajek P, Tonstad S, Dautzenberg B, Fletcher M, Masefield S, Powell P, Hering T, Nardini S, Tonia T, Gratziou C. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J. 2015 Jul;46(1):61-79. doi: 10.1183/09031936.00092614. Epub 2015 Apr 16.

  PMID: 25882805 RESULT

• Karadogan D, Onal O, Kanbay Y. How does reimbursement status affect smoking cessation interventions? A real-life experience from the Eastern Black Sea region of Turkey. Tob Induc Dis. 2019 Jan 22;17:05. doi: 10.18332/tid/100412. eCollection 2019.

  PMID: 31582917 RESULT

• Williams PJ, Philip KEJ, Gill NK, Flannery D, Buttery S, Bartlett EC, Devaraj A, Kemp SV, Addis J, Derbyshire J, Chen M, Morris K, Laverty AA, Hopkinson NS. Immediate, Remote Smoking Cessation Intervention in Participants Undergoing a Targeted Lung Health Check: Quit Smoking Lung Health Intervention Trial, a Randomized Controlled Trial. Chest. 2023 Feb;163(2):455-463. doi: 10.1016/j.chest.2022.06.048. Epub 2022 Aug 4.

  PMID: 35932889 RESULT

• Buttery SC, Williams P, Mweseli R, Philip KEJ, Sadaka A, Bartlett EJ, Devaraj A, Kemp S, Addis J, Derbyshire J, Chen M, Morris K, Laverty A, Hopkinson NS. Immediate smoking cessation support versus usual care in smokers attending a targeted lung health check: the QuLIT trial. BMJ Open Respir Res. 2022 Feb;9(1):e001030. doi: 10.1136/bmjresp-2021-001030.

  PMID: 35121633 RESULT

• Karadogan D, Telatar TG, Kaya I, Atli S, Kabil NK, Marim F, Senel MY, Yuksel A, Yalcin B, Gultekin O, Ercelik M, Akgun M. Immediately scheduled for an appointment to smoking cessation clinics: Key to quitting smoking in chronic airway disease - a multicenter randomized study. Tob Induc Dis. 2025 Jun 5;23. doi: 10.18332/tid/204254. eCollection 2025.

  PMID: 40475312 DERIVED

MeSH Terms

Conditions

Tobacco Use Cessation; Asthma; Pulmonary Disease, Chronic Obstructive; Bronchiectasis

Condition Hierarchy (Ancestors)

Health Behavior; Behavior; Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Dilek Karadoğan

  Recep Tayyip Erdogan University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associated Professor Doctor, MD

Study Record Dates

• First Submitted: February 11, 2023
• First Posted: March 10, 2023
• Study Start: November 15, 2022
• Primary Completion: June 15, 2023
• Study Completion: September 15, 2023
• Last Updated: November 24, 2023

Record last verified: 2023-11

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)